Clinical trial
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
NCT00130481 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00130481 |
|---|---|
| Title | Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) |
| Official title | Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) |
| Lead sponsor | University of Florida, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Atorvastatin 20 mg daily for 3 months |
| Enrollment | 100 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Aug 15, 2005 |
| Last update posted | Mar 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: